ENCLOMIPHENE

Enclomiphene, developed by Repros Therapeutics Inc, is a nonsteroidal estrogen receptor antagonist that promotes testosterone secretion by increasing levels of gonadotropin produced by the testes. Enclomiphene constitutes the trans-stereoisomer of clomiphene citrate, a widely prescribed drug for several decades for the treatment of female ovulatory dysfunction. Because of enclomiphene’s antagonistic effects, the drug has […]